路透 - 视频

版本: US | UK | IN | CN | JP

video

Breakingviews TV: Botox Tuesday

2019年 6月 26日 星期三 - 03:21

AbbVie is buying Allergan, maker of Botox, for $63 billion – a 45% premium. It’s a great deal for the seller’s shareholders, but not much more than an overpriced superficial filler for the buyer. Robert Cyran explains the wrinkles in the merger.

▲ 隐藏详情

显示详情

AbbVie is buying Allergan, maker of Botox, for $63 billion – a 45% premium. It’s a great deal for the seller’s shareholders, but not much more than an overpriced superficial filler for the buyer. Robert Cyran explains the wrinkles in the merger.

分享到  - 微信
路透中文网

Breakingviews TV: Botox Tuesday

2019年 6月 26日 星期三 - 03:21